AII-trans retinoic acid (RA) represents a major advance that has made acute promyelocytic leukemia (APL) the most curable subtype of acute myeloid leukemia in adults. Although, RA's overall toxicity is considerably less compared to the standard toxic chemotherapy, its use has been associated with the development of a potentially fatal condition called, RA syndrome. The only drug available for preventing RA syndrome is the high dose of dexamethasone, even though its mechanism of action is not understood. The pathogenesis of RA syndrome and management remains to be the challenge for the present. The syndrome is typical of APL patients; it neither occurs in individuals taking RA for other reasons nor the APL patients treated with chemotherapy alone develop this condition. More specifically, the syndrome has not been observed in APL patients receiving RA during complete remission. Based on these observations, it is postulated that RA syndrome may represents a secondary event related to the aberrant interaction between differentiating myeloid cells and host tissues. Based on our initial observations that: a) RA-is a potent inducer of cell-surface CD38 antigen expression in APL cells; b) CD38 antigen can serve as a receptor and its ligation can induce potent growth-stimulatory and inflammatory signals; and c) human lung endothelial cells express a cell-surface protein that can serve as a putative CD38 ligand; we propose that RA-induced CD38 antigen may play a central role in the development of RA syndrome pathogenesis. Thus, RA-induced CD38 antigen may result in an increased adherence between CD38-positive maturing APL cells and the endothelium of lung capillaries. This initial step may generate the congestive clinical picture and induce (or may determine) an uncontrolled cytokine release. The studies proposed in this grant application will address in depth the involvement of CD38 antigen in promoting the adhesion of RA-induced APL cells to lung endothelial cells and consequence and contribution of such interaction in the development of RA syndrome. By accomplishing the stated aims, we hope to define the molecular mechanisms involved in the pathogenesis of RA syndrome, the knowledge that will help design better approaches to control this potentially fatal condition. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092115-02
Application #
6744290
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Mccarthy, Susan A
Project Start
2003-05-01
Project End
2007-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
2
Fiscal Year
2004
Total Cost
$251,038
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Han, Amy Lee; Kumar, Santosh; Fok, Jansina Y et al. (2014) Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor. Eur J Cancer 50:1685-96
Vivas-Mejia, Pablo; Benito, Juliana Maria; Fernandez, Ariel et al. (2010) c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res 16:184-94
Tsimberidou, Apostolia-Maria; Kantarjian, Hagop M; Wen, Sijin et al. (2008) Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer 113:1370-8
Hwang, Jee Young; Mangala, Lingegowda S; Fok, Jansina Y et al. (2008) Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res 68:5849-58
Verma, Amit; Guha, Sushovan; Wang, Huamin et al. (2008) Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res 14:1997-2005
Tsimberidou, Apostolia-Maria; Kantarjian, Hagop M; Wen, Sijin et al. (2008) The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients. Clin Cancer Res 14:721-30
Akar, Ugur; Ozpolat, Bulent; Mehta, Kapil et al. (2007) Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res 5:241-9
Gao, Yin; Mehta, Kapil (2007) N-linked glycosylation of CD38 is required for its structure stabilization but not for membrane localization. Mol Cell Biochem 295:1-7
Gao, Yin; Camacho, Luis H; Mehta, Kapil (2007) Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome. Leuk Res 31:455-63
Verma, Amit; Wang, Huamin; Manavathi, Bramanandam et al. (2006) Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 66:10525-33

Showing the most recent 10 out of 12 publications